| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| BELLICUM PHARMACEUTICALS, INC | Chief Development Officer | Stock Option (right to buy) | 250,000 | $360,000 | $1.44 | 15 Aug 2022 | Direct |
| BELLICUM PHARMACEUTICALS, INC | Chief Development Officer | Common Stock | 14,587 | 01 Dec 2021 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| /report/000162828022023031-scripture-charity-2022-08-15 | BELLICUM PHARMACEUTICALS, INC | 15 Aug 2022 | 1 | +$360,000 | 4 | Chief Development Officer | 16 Aug 2022, 17:04 |
| /report/000189594821000004-scripture-charity-2021-12-01 | BELLICUM PHARMACEUTICALS, INC | 01 Dec 2021 | 1 | +$259,500 | 4 | Chief Development Officer | 02 Dec 2021, 14:23 |
| /report/000189594821000002-scripture-charity-2021-12-01 | BELLICUM PHARMACEUTICALS, INC | 01 Dec 2021 | 0 | $0 | 3 | Chief Development Officer | 02 Dec 2021, 14:21 |